| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mgcd516 | vascular endothelial growth factor receptor 3 | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2/3 | unknown |
| mgcd516 | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2/3 | unknown |
| mgcd516 | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | phase 2/3 | unknown |
| mgcd516 | proto-oncogene c-ret | NA | Successful target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of breast[MeSHID:D001943] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | phase 2/3 | unknown |
| click here to return to the previous page | ||||||||